Monitoring response to disease-modifying treatment in multiple sclerosis
Background: Standard criteria for defining suboptimal response to disease-modifying treatment (DMT) in patients with multiple sclerosis (MS) are lacking. Decision-making on how and when DMTs should be switched is challenging. The objective of the study was to identify areas of agreement on which and...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-04-01
|
Series: | Neurology Perspectives |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S266704962300011X |